BSEAGM/EGM2d ago · 1 Oct 2026, 04:12 pm
Scrutinizers Report
Kabra Drugs Ltd · 524322
✦ AI Summary
Kabra Drugs Ltd has submitted the voting results of its 37th Annual General Meeting, held on September 30, 2026, as per SEBI regulations.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kabra Drugs Ltd - 524322 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Attachments (1)
📄pdf
Download →
99e1fa51-d652-4bdb-9b2a-097b7766244c.pdf
View document text
Date: 01st October 2026
BSE Limited
Phiroze Jeejeebhoy Towers,
21st Floor, Dalal Street,
Mumbai-400 001.
BSE Scrip Code: 524322
Sub: Voting Results of the 37 th Annual General Meeting of the Company - Regulation
30 and 44(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regula-
tions, 2015.
Pursuant to Regulation 30 and 44(3) of the SEBI (Listing Obligations and Disclosures
Requirements) Regulations, 2015, we submit herewith the voting results of the business
transacted at the 37th Annual General Meeting of the Company held on 30th September
2026, Wednesday at 09:00 A.M at Fairfield by Marriott Hotel, 169 Rajiv Gandhi Salai, Old,
Mahabalipuram Road, Semmancheri, Chennai-600119 in the prescribed format.
Kindly take the same on record and acknowledge the receipt.
Thanking You,
Yours Faithfully,
For and Behalf of the Board of Directors of
Aanjaay Industries Limited
(Formerly known as Kabra Drugs Limited)
Nanjappan Aravind
Managing Director
DIN: 01895602